Guided Therapeutics (GTHP) Cash from Operations (2016 - 2026)
Guided Therapeutics (GTHP) posted Cash from Operations of 291000.0 for Q4 2025, down 5.05% sequentially from 277000.0 in Q3 2025, and up 12.35% YoY from 259013.4 in Q4 2024.
Guided Therapeutics (GTHP) Cash from Operations (2016 - 2026) Analysis & Trends
Guided Therapeutics has reported Cash from Operations for 10 years, with the latest figure at 291000.0 in Q4 2025.
- Quarterly Cash from Operations rose 12.35% year-over-year to 291000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1068000.0 (up 4.56% YoY) and the FY2025 annual result came in at 1068000.0, up 4.56% from the prior year.
- Cash from Operations fell to 291000.0 in Q4 2025 per GTHP's latest filing, from 277000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 159000.0 in Q4 2021 and troughed at 739000.0 in Q3 2021.
- A 5-year average of 350200.0 and a median of 334000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2021 and 2022: Cash from Operations jumped 148.04% in 2021, then sank 313.21% in 2022.
- Over 5 years, Cash from Operations stood at 159000.0 in 2021, then slumped by 313.21% to 339000.0 in 2022, then grew by 0.88% to 336000.0 in 2023, then increased by 1.19% to 332000.0 in 2024, then rose by 12.35% to 291000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 291000.0, 277000.0, and 169000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -319,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -319,000.00 |
| Jun 30, 2026 | -319,000.00 |
| Mar 31, 2026 | -617,000.00 |
| Mar 31, 2026 | -617,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |